New! Rigvir SE
The world's
first food supplement with a live virus.
An effective way to prevent cancer. Order Now!
Information center
info@virotherapy.com
+1 202 769 5306 
IVC recent topics
Recent clinical publications
Oncolytic virus preclinical toxicology studies
Stage IIA Skin Melanoma Treatment With ECHO-7 Oncolytic Virus Rigvir
4-Week repeated dose rat GLP toxicity study of oncolytic ECHO-7 virus Rigvir administered intramuscularly with a 4-week recovery period
Clinical landscape of oncolytic virus research in 2020
The Oncolytic Virus in Cancer Diagnosis and Treatment
A progressive stage IIIB melanoma treated with oncolytic ECHO-7 virus: A case report
Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report
Adrenal Gland and Gastric Malignant Melanoma without Evidence of Skin Lesion Treated with the Oncolytic Virus Rigvir
Effect of oncolytic ECHO-7 virus strain Rigvir on uveal melanoma cell lines
ECHO-7 oncolytic virus Rigvir® in an adjuvant setting for stage I uveal melanoma; A retrospective case report
Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir.
Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient.
A Case of Stage IV Chromophobe Renal Cell Carcinoma Treated with the Oncolytic ECHO-7 Virus, Rigvir®
Oncolytic viruses are a fast-developing cancer treatment field. Numerous viruses have been tested in clinical trials and three are approved. The first, Rigvir, is an immunomodulator with anti-tumour effect
Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery
Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin in vitro
Melanoma Unknown Primary Brain Metastasis Treatment with ECHO-7 Oncolytic Virus Rigvir: A Case Report
Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports
Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumor in a retrospective study
)
© 2024 International Virotherapy Center Limited. All Rights Reserved